Full data view for gene PMS2


PMS2 variants classified by the InSiGHT consortium: criteria used for classification are available here. We encourage submission of relevant unpublished information to assist in the classification of variants via LOVD or this template which can be emailed to the curator.
Information The variants shown are described using the NM_000535.6 transcript reference sequence.

3 entries on 1 page. Showing entries 1 - 3.
Legend   How to query  

Effect     

Exon     

AscendingDNA change (cDNA)     

RNA change     

Protein     

Allele     

Classification method     

Clinical classification     

DNA change (genomic) (hg19)     

DNA change (hg38)     

Published as     

ISCN     

DB-ID     

Variant remarks     

Reference     

ClinVar ID     

dbSNP ID     

Origin     

Segregation     

Frequency     

Re-site     

VIP     

Methylation     

Template     

Technique     

Tissue     

Remarks     

Disease     

ID_report     

Reference     

Remarks     

Gender     

Consanguinity     

Country     

Population     

Age at death     

VIP     

Data_av     

Treatment     

Panel size     

Owner     
+/. 10i_12i c.(1144+1_1145-1)_(2174+1_2175-1)dup r.spl? p.? Unknown - pathogenic g.(6018328_6022454)_(6027252_6029430)dup - Ex11-12 duplication; c.(1144+1_1145-1)_(2174+1_?) - PMS2_000449 RNA & DNA analysis by Carli Topps indicates the duplication is a tandem out-of-frame insertion in PMS2: "A specific primerset was developed for identification of a tandem exon 11 + exon 12 duplication, on DNA as well as on RNA. Result There is a duplication of exon 11 + exon 12, inserted in intron 12. This could be shown on DNA as well as on RNA. This tandem duplication is predicted to result in an out-frame insertion and early truncation of the PMS2 protein. " Please note - ambiguity exists in determining 3' extent of duplication due to presence of pseudogenes for PMS2 ex12 onwards. 3' limit (exon 12) and location (tandem duplication within gene) confirmed in case 1 by RNA analysis, and inferred in cases 2 and 3 due to identical MLPA results. - - - Germline - - - - - DNA MLPA, SEQ-NG - - HNPCC1 - - CRC aged 46 in proband. No additional family testing that we're aware of. - - - - - - - - 1 Ian Berry
+/. 10i_12i c.(1144+1_1145-1)_(2174+1_2175-1)dup r.spl? p.? Unknown - pathogenic g.(6018328_6022454)_(6027252_6029430)dup - Ex11-12 duplication; c.(1144+1_1145-1)_(2174+1_?) - PMS2_000449 Patient with constitutional mismatch repair deficiency (CMMRD). Patient heterozygous for c.137G>T (class 4) and ex11-12 duplication. Phase could not be confirmed in parents. Please note - ambiguity exists in determining 3' extent of duplication due to presence of pseudogenes for PMS2 ex12 onwards. 3' limit (exon 12) and location (tandem duplication within gene) confirmed in case 1 by RNA analysis, and inferred in cases 2 and 3 due to identical MLPA results. - - - Germline - - - - - DNA MLPA, SEQ-NG - - HNPCC1 - - CRC aged 17 and again at 24; histological profile consistent with CMMRD. Patient heterozygous for c.137G>T (class 4) and ex11-12 duplication. Phase could not be confirmed in parents. - - - - - - - - 1 Ian Berry
+/. 10i_12i c.(1144+1_1145-1)_(2174+1_2175-1)dup r.spl? p.? Unknown - pathogenic g.(6018328_6022454)_(6027252_6029430)dup - Ex11-12 duplication; c.(1144+1_1145-1)_(2174+1_?) - PMS2_000449 Please note - ambiguity exists in determining 3' extent of duplication due to presence of pseudogenes for PMS2 ex12 onwards. 3' limit (exon 12) and location (tandem duplication within gene) confirmed in case 1 by RNA analysis, and inferred in cases 2 and 3 due to identical MLPA results. - - - Germline - - - - - DNA MLPA, SEQ-NG - - HNPCC1 - - Patient had CRC @48yo. Father had CRC @58yo, isolated PMS2 loss on tumour. Duplication could not be tested as deceased. - - - - - - - - 1 Ian Berry
Legend   How to query  


Screenscraping/webscraping (downloading large amounts of data using scripts) is strictly prohibited.
Use our APIs to retrieve data.